Skip to main content
Allogeneic Hematopoetic Stem Cell Transplantation for Children with Acute Lymphoblastic Leukemia in the Era of Immunotherapy
ScienceLeukemiaPublicationEU-CAYAS-NET

Allogeneic Hematopoetic Stem Cell Transplantation for Children with Acute Lymphoblastic Leukemia in the Era of Immunotherapy

Childhood Leukemia Treatment 2022: where we are now and what it takes

Published:

The international FORUM study led by Prof. Christina Peters was so successful that the journal Frontiers in Pediatrics made a special kind of request: The experts in this field were invited to bring out an entire Research Topic on acute lymphoblastic leukaemia in children.

The result: 24 scientific articles by 105 authors addressing better-tolerable treatments with allogeneic stem cell transplantation and modern options for a cure without stem cell transplantation.

This article provides informational support only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider for medical decisions.

EU-CAYAS-NET project logo

This content was created during the EU-CAYAS-NET project, co-funded under the EU4Health Programme in 2022-2025 (Grant Agreement No. 101056918).